IMVARIA Announces FDA De Novo Marketing Authorization of Fibresolve, an AI Biomarker in Lung Fibrosis, and the Adoption of Novel CPT Billing Codes by the American Medical Association

Press Release IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for the use of Fibresolve, a digital biomarker solution that uses…

Related Keywords

United States ,Stanford University ,California ,Berkeley ,Stanford ,American ,Joshua Mooney ,Joshua Reicher ,Anthony Petrucci ,Michael Muelly ,Drug Administration ,American Medical Association ,Digital Biomarker Lab ,Google ,Authorized Breakthrough ,Fibresolve Breakthrough Device ,Clinical Assistant Professor ,Critical Care ,Stanford Medicine ,Multidisciplinary Discussion ,